Rasayanam Upgrades Ashwagandha KSM-66® Formula to Clinically Proven 600 mg Dosage
Wellness brand Rasayanam has upgraded its Ashwagandha supplement to a 600 mg dosage to align with clinical research findings. The company aims to provide evidence-based products that address consumer demand for efficacy in stress and sleep management.
Why it matters
This reflects a growing trend in the supplement industry toward science-backed formulations and transparency in consumer health products.
Faridabad, India – June 1, 2026: As consumers increasingly seek science-backed wellness solutions, Rasayanam has announced the launch of its upgraded Ashwagandha KSM-66® formula, now delivering 600 mg per serving — a dosage widely supported by clinical research for optimal efficacy and measurable results.
The article is a straightforward report on a product update and company strategy without political or social bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in